Understanding Semaglutide Compounded Safety Compared to Wegovy
Comments Off on Understanding Semaglutide Compounded Safety Compared to Wegovy
June 10, 2026
Semaglutide compounded safety is a critical consideration for clinicians and patients. Unlike FDA-approved Wegovy, compounded semaglutide lacks consistent quality control and regulatory oversight. This variability can impact treatment efficacy and…
Clinical Evidence and Safety Concerns of Compounded Semaglutide
Comments Off on Clinical Evidence and Safety Concerns of Compounded Semaglutide
May 9, 2026
Compounded semaglutide safety concerns arise due to lack of FDA oversight, leading to variable potency and purity. Clinical evidence shows compounded products differ from FDA-approved semaglutide in quality control. Prescribers must counsel patients on…